A salt could wipe-out diabetes?

These Swedes say that diabetes is a VIRUS.

https://patents.justia.com/assignee/curovir-ab

Their invention seems to kill all viruses.

Patents by Inventor Jacob Westman

https://patents.justia.com/inventor/jacob-westman

Clanotech AB is the assignee on many of his patents

The largest shareholder in Clanoech AB is Rosetta Capital IV S.à r.l. [LUXEMBOURG] Rosetta Capital is a specialist venture capital firm focused in the life science and medical technology sectors. Rosetta is headquartered in the United Kingdom and manages funds comprising more than 30 active portfolio companies across Europe, North America and Asia.

The second largest shareholder is founder Yihai Cao, MD PhD, Professor at the Microbiology and Tumor Biology Center at Karolinska Institutet, Sweden, specialized in regulation of angiogenesis.

Rosetta is a globalist organization https://sec.report/CIK/Search/Rosetta+Co.%2C+Limited

Curovir AB is the assignee on the diabetes virus killer salt patents

Pyrazolo[1,5-a]triazin-4-amine derivatives useful in therapy

Patent number: 10407429

Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof, useful in therapy, in particular in the treatment of a viral infection.

Type: Grant

Filed: June 10, 2016

Date of Patent: September 10, 2019

Assignee: Curovir AB

Inventor: Jacob Westman

Pyrazolo[1,5-a]pyrimidines as antiviral compounds

Patent number: 9963455

Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof, useful in therapy, in particular in the treatment of a viral infection.

Type: Grant

Filed: January 21, 2015

Date of Patent: May 8, 2018

Assignee: Curovir AB

Inventor: Jacob Westman

1,2,4-thiazolidin-3-one derivatives and their use in the treatment of cancer

Patent number: 9675596

Abstract: According to the invention there is provided a compound of formula (I) wherein: A represents C(?N—W-D) or S; B represents S or C(—NH—W-D); when: A represents C(?N—W-D) and B represents S then the bond between B and the NH atom is a single bond; or A represents S and B represents C(—NH—W-D) then the bond between B and the NH atom is a double bond; X represents -Q-[CRxRy]n—; W represents —[CRxRy]m— or —C(O)—[CRxRy]p—; Q represents a bond, —N(Ra)—; —S—, or —O—; A1 to A5 respectively represent C(R1), C(R2), C(R3), C(R4) and C(R5), or, alternatively, up to two of A1 to A5 may independently represent N; D represents phenyl, pyridyl or pyrimidinyl optionally substituted by one or more R6 groups, which compounds are useful in the treatment of cancer.

Type: Grant

Filed: October 14, 2015

Date of Patent: June 13, 2017

Assignee: Baltic Bio AB https://www.healtheuropa.eu/ampk-o304-diabetic-kidney-disease/86703/ https://news.cision.com/betagenon-ab/r/betagenon-baltic-bio-announces-positive-results-from-a-28-day-phase-iia-trial-of-the-first-in-class-,c2381342

Inventors: Jacob Westman, Allan Hallett, Jan Vagberg

1,2,4-thiazoloidin-3-one derivatives and their use in the treatment of cancer

Patent number: 9162994

Abstract: According to the invention there is provided a compound of formula (I) wherein: A represents C(?N—W-D) or S; B represents S or C(—NH—W-D); when: A represents C(?N—W-D) and B represents S then the bond between B and the NH atom is a single bond; or A represents S and B represents C(—NH—W-D) then the bond between B and the NH atom is a double bond; X represents -Q-[CRxRy]n—; W represents —[CRxRy]m— or —C(O)—[CRxRy]p—; Q represents a bond, —N(Ra)—, —S—, or —O—; A1 to A5 respectively represent C(R1), C(R2), C(R3), C(R4) and C(R5), or, alternatively, up to two of A1 to A5 may independently represent N; D represents phenyl, pyridyl or pyrimidinyl optionally substituted by one or more R6 groups, which compounds are useful in the treatment of cancer.

Type: Grant

Filed: July 8, 2010

Date of Patent: October 20, 2015

Assignee: BETAGENON AB https://betagenon.com/about-us/leadership/ Associated with Eli Lilly (2010-2018), AstraZeneca PLC (2000-2009), https://betagenon.com/about-us/board-of-directors/

Inventors: Jacob Westman, Allan Hallett, Jan Vågberg

Quinoline derivatives and their use as tyrosine kinase inhibitors

Patent number: 8957092

Abstract: A compound of formula 6-(methylcarbamoyl)-4-[(4-methylphenyl)amino]quinoline-3-carboxylic acid, and pharmaceutically acceptable salts thereof, is provided. The compound can be used to treat cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema and psoriasis.

Type: Grant

Filed: August 30, 2013

Date of Patent: February 17, 2015

Assignee: ClanoTech AB

Inventors: Jacob Westman, Natalia Nekhotiaeva, Johan Wannberg, Ulrika Backman, Johan Malm

Quinoline derivatives and their use as tyrosine kinase inhibitors

Patent number: 8557843

Abstract: A compound of formula (I) as well as pharmaceutically acceptable salts thereof. A pharmaceutical composition having a therapeutically effective amount of the compound. The compound is useful for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema or psoriasis.

Type: Grant

Filed: November 14, 2008

Date of Patent: October 15, 2013

Assignee: ClanoTech AB

Inventors: Jacob Westman, Natalia Nekhotiaeva, Johan Wannberg, Ulrika Backman, Johan Malm

Azabicyclooctan-3-one derivatives and use thereof

Patent number: 7759361

Abstract: Compounds of Formula (1) process for preparing them, pharmaceutical compositions comprising them. The use of compounds of formula (1) for hyperproliferative diseases, e.g. cancer as well as autoimmune diseases and heart disease.

Type: Grant

Filed: March 22, 2005

Date of Patent: July 20, 2010

Assignee: Aprea AB

Inventors: Jacob Westman, Klas Wiman, Galina Selivanova, Vladimir Bykov

Method for performing multiple chemical reactions and a kit and system therefor

Patent number: 7112450

Abstract: The present invention relates to conducting a plurality of chemical reactions in a system including an apparatus which provides energy for the chemical reactions, such as chemical reactions in organic synthesis, where a particular advantage is the use of predetermined reaction parameters corresponding to similar chemical reactions. The present invention also relates to a system for performing said method and to corresponding kits and software. The system comprises an apparatus which can provide energy for the chemical reactions, said apparatus comprising a reaction cavity and a liquid handler, and a parameter selecting unit having a user interface means, a search unit means, apparatus control unit means, and storage means for carrying a database.

Type: Grant

Filed: May 7, 2001

Date of Patent: September 26, 2006

Assignee: Personal Chemistry I Uppsala AB

Inventors: Magnus Fagrell, Jacob Westman

Preparation and use of ionic liquids in microwave-assisted chemical transformations

Patent number: 6596130

Abstract: Ionic liquids were rapidly and efficiently prepared by microwave-assisted chemical transformations. A method for performing microwave-assisted reactions, including alkylation reactions, using ionic liquids as solvent resulted in high yields with dramatically reduced reaction times. Ionic liquids, when used as an additive or co-solvent, allowed for heating, by microwave-assistance, of chemical reactions performed in traditional organic solvents, most notably non-polar solvents.

Type: Grant

Filed: November 26, 2001

Date of Patent: July 22, 2003

Assignee: Personal Chemistry i Uppsala AB

Inventor: Jacob Westman

https://patents.justia.com/patent/10407429

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=4&f=G&l=50&co1=AND&d=PTXT&s1=Ljungan&OS=Ljungan&RS=Ljungan